Donald Trump has signed an executive order speeding up reviews of psychedelic drugs – including for ibogaine, touted as a possible treatment for post-traumatic stress disorder.
June 5, 2026

Donald Trump has signed an executive order speeding up reviews of psychedelic drugs – including for ibogaine, touted as a possible treatment for post-traumatic stress disorder.